Financial Gravity Asset Management’s Integra LifeSciences IART Stock Holding History

Financial Gravity Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41	Closed	-$778	–	1486
2023 Q2	$778	Buy	+41	New	+$1.97K	﹤0.01%	877
2021 Q3	–	Sell	-45	Closed	-$68K	–	974
2021 Q2	$68K	Sell	45 -1	-2%	-$71	0.02%	468
2021 Q1	$3.21K	Buy	+46	New	+$3.12K	0.07%	189
2019 Q4	–	Sell	-300	Closed	-$18K	–	1535
2019 Q3	$18K	Buy	+300	New	+$17.9K	0.02%	477
2018 Q3	$49K	Buy	+791	New	+$49.2K	0.05%	329
2018 Q2	–	Sell	-175	Closed	-$11K	–	1500
2018 Q1	$11K	Buy	+175	New	+$9.17K	0.01%	576

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Gravity Asset Management's IART Position: Q3 2023 in Review

Financial Gravity Asset Management sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 41 shares — an estimated $778 sold.

Financial Gravity Asset Management first reported a position in IART in Q1 2018 and held it in 6 quarters. The position peaked at $68K in Q2 2021. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

Financial Gravity Asset Management reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
Financial Gravity Asset Management sold 41 Integra LifeSciences shares in Q3 2023, an estimated $778.
Financial Gravity Asset Management first reported a position in Integra LifeSciences in Q1 2018 and held it in 6 quarters.
Financial Gravity Asset Management's Integra LifeSciences position peaked at $68K in Q2 2021.
262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Financial Gravity Asset Management's 13F filing for Q3 2023, filed 16 Nov 2023.